Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1533 ARTÍCULOS , VIENDO DEL 1486 AL 1500

[Memantine: from the original brand to generics]

Titova NV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(10):136-143. doi: 10.17116/jnevro2017117101136-143.

Cognitive profile in prodromal disease (dementia) with Lewy bodies

Kemp J, Philippi N, Phillipps C, Botzung A, Blanc F.

Geriatr Psychol Neuropsychiatr Vieil. 2017 Dec 1;15(4):434-442. doi: 10.1684/pnv.2017.0700.

Similarity and Differences in Inflammation-Related Characteristics of the Peripheral Immune System of Patients with Parkinson's and Alzheimer's Diseases

Boyko AA, Troyanova NI, Kovalenko EI, Sapozhnikov AM.

Int J Mol Sci. 2017 Dec 6;18(12):2633. doi: 10.3390/ijms18122633.

Two Novel Mutations in the First Transmembrane Domain of Presenilin1 Cause Young-Onset Alzheimer's Disease

Liu CY, Ohki Y, Tomita T, Osawa S, Reed BR, Jagust W, Van Berlo V, Jin LW, Chui HC, Coppola G, Ringman JM.

J Alzheimers Dis. 2017;58(4):1035-1041. doi: 10.3233/JAD-161203.

Signs and symptoms preceding the diagnosis of Alzheimer's disease: a systematic scoping review of literature from 1937 to 2016

Bature F, Guinn BA, Pang D, Pappas Y.

BMJ Open. 2017 Aug 28;7(8):e015746. doi: 10.1136/bmjopen-2016-015746.

A case series of PLS patients with frontotemporal dementia and overview of the literature

de Vries BS, Rustemeijer LMM, van der Kooi AJ, Raaphorst J, Schröder CD, Nijboer TCW, Hendrikse J, Veldink JH, van den Berg LH, van Es MA.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Nov;18(7-8):534-548. doi: 10.1080/21678421.2017.1354996. Epub 2017 Jul 26.

Glucose Transporters in Brain: In Health and in Alzheimer's Disease

Szablewski L.

J Alzheimers Dis. 2017;55(4):1307-1320. doi: 10.3233/JAD-160841.

Oxidative stress in neurodegenerative disease: causation or association?

Van Raamsdonk JM, Vega IE, Brundin P.

Oncotarget. 2017 Feb 14;8(7):10777-10778. doi: 10.18632/oncotarget.14650.

Risk factors for the onset and progression of Huntington disease

Chao TK, Hu J, Pringsheim T.

Neurotoxicology. 2017 Jul;61:79-99. doi: 10.1016/j.neuro.2017.01.005. Epub 2017 Jan 20.

Treatment of Agitation in Huntington's Disease With Electroconvulsive Therapy

Shah RP, Alluri V, Sharma S.

J Neuropsychiatry Clin Neurosci. 2017 Summer;29(3):293-294. doi: 10.1176/appi.neuropsych.16080161. Epub 2017 Jan 25.

Co-occurring frontal variant Alzheimer's dementia and carrier of Huntington's disease allele with reduced penetrance

Rawtaer I, Krishnamoorthy A.

Psychogeriatrics. 2017 Nov;17(6):488-490. doi: 10.1111/psyg.12246. Epub 2017 Jan 27.

Data quality assurance and control in cognitive research: Lessons learned from the PREDICT-HD study

Westervelt HJ, Bernier RA, Faust M, Gover M, Bockholt HJ, Zschiegner R, Long JD, Paulsen JS; PREDICT-HD Investigators; Coordinators of the Huntington Study Group.

Int J Methods Psychiatr Res. 2017 Sep;26(3):e1534. doi: 10.1002/mpr.1534. Epub 2017 Feb 17.

7T MRI for neurodegenerative dementias in vivo: a systematic review of the literature

McKiernan EF, O'Brien JT.

J Neurol Neurosurg Psychiatry. 2017 Jul;88(7):564-574. doi: 10.1136/jnnp-2016-315022. Epub 2017 Mar 4.

Biological Basis for Amyloidogenesis in Alzheimer's Disease

Andreeva TV, Lukiw WJ, Rogaev EI.

Biochemistry (Mosc). 2017 Feb;82(2):122-139. doi: 10.1134/S0006297917020043.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias